Trial intelligence / Profile preview

Combination Therapy in Dual Diagnosis Rapid Cycling Bipolar Disorder

NCT00221975Phase 3Completed

Sponsor
University Hospitals Cleveland Medical Center
Start
Jul 2002
Primary completion
Jun 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of lamotrigine in bipolar disorder (BD), sponsored by University Hospitals Cleveland Medical Center. Started Jul 2002; status: completed.

02

Drugs

lamotrigine
03

Conditions

bipolar disorder (BD)

Beyond the preview

Go deeper on NCT00221975.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00221975.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call